Testing Our Limits, Episode 1: A Threat Emerges

It’s late in 2019. As word of a new respiratory illness is coming in, Abbott immediately mobilizes to find ways to compress the time it takes to develop a test for production. What traditionally takes years must happen in weeks.

“Everybody came back from holiday in January. The situation was getting worse and not better. So we started, internally, R&D leaders, exchanging emails with each other what have we learned. Quickly, our weekly meetings became daily,” said Katharine Qiu, Ph.D., vice president for infectious disease research and development, Abbott Rapid Diagnostics.

Learn more about how Abbott’s diagnostics are helping to slow the COVID-19 pandemic: https://abbo.tt/37ht6os

Subscribe to the Abbott Channel and receive automatic updates: https://www.youtube.com/channel/UC346EX3v26ACsjLhe-HwHDg/?sub_confirmation=1

Find out more about us and our products on http://www.abbott.com/

Connect with us on ...
Facebook: https://www.facebook.com/Abbott/
Twitter: https://twitter.com/abbottnews
Instagram: https://www.instagram.com/abbottglobal/
LinkedIn: https://www.linkedin.com/company/abbott-/
YouTube: https://www.youtube.com/channel/UC346EX3v26ACsjLhe-HwHDg/featured